240 related articles for article (PubMed ID: 25591759)
1. Inflammatory cytokine TSLP stimulates platelet secretion and potentiates platelet aggregation via a TSLPR-dependent PI3K/Akt signaling pathway.
Dong J; Lin J; Wang B; He S; Wu C; Kushwaha KK; Mohabeer N; Su Y; Fang H; Huang K; Li D
Cell Physiol Biochem; 2015; 35(1):160-74. PubMed ID: 25591759
[TBL] [Abstract][Full Text] [Related]
2. Human platelets express functional thymic stromal lymphopoietin receptors: a potential role in platelet activation in acute coronary syndrome.
Wang B; Peng Y; Dong J; Lin J; Wu C; Su Y; Fang H; Wang L; Huang K; Li D
Cell Physiol Biochem; 2013; 32(6):1741-50. PubMed ID: 24356513
[TBL] [Abstract][Full Text] [Related]
3. A Potential Mechanism of High-Dose Ticagrelor in Modulating Platelet Activity and Atherosclerosis Mediated by Thymic Stromal Lymphopoietin Receptor.
Mao Y; Peng Y; Zeng Q; Cheng L; Wang B; Mao X; Meng K; Liu Y; Lian Y; Li D
PLoS One; 2015; 10(10):e0141464. PubMed ID: 26517374
[TBL] [Abstract][Full Text] [Related]
4. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling.
Borst O; Münzer P; Gatidis S; Schmidt EM; Schönberger T; Schmid E; Towhid ST; Stellos K; Seizer P; May AE; Lang F; Gawaz M
Circ Res; 2012 Oct; 111(10):1297-307. PubMed ID: 22927331
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
[TBL] [Abstract][Full Text] [Related]
6. TSLP protects against liver I/R injury via activation of the PI3K/Akt pathway.
Li S; Yi Z; Deng M; Scott MJ; Yang C; Li W; Lei Z; Santerre NM; Loughran P; Billiar TR
JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723054
[TBL] [Abstract][Full Text] [Related]
7. TSLP/TSLPR promote angiogenesis following ischemic stroke via activation of the PI3K/AKT pathway.
Yu X; Peng Y; Liang H; Fu K; Zhao Z; Xie C; Zhou L; Zhang K
Mol Med Rep; 2018 Feb; 17(2):3411-3417. PubMed ID: 29257253
[TBL] [Abstract][Full Text] [Related]
8. A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B.
Lova P; Paganini S; Hirsch E; Barberis L; Wymann M; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2003 Jan; 278(1):131-8. PubMed ID: 12407113
[TBL] [Abstract][Full Text] [Related]
9. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
[TBL] [Abstract][Full Text] [Related]
11. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
[TBL] [Abstract][Full Text] [Related]
12. Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161.
Yi W; Li Q; Shen J; Ren L; Liu X; Wang Q; He S; Wu Q; Hu H; Mao X; Zhu L
PLoS One; 2014; 9(8):e102394. PubMed ID: 25115838
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor-induced Akt activation--regulation and possible function.
Reséndiz JC; Kroll MH; Lassila R
J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592
[TBL] [Abstract][Full Text] [Related]
14. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation.
Delaney MK; Liu J; Zheng Y; Berndt MC; Du X
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2761-8. PubMed ID: 22995516
[TBL] [Abstract][Full Text] [Related]
15. Blockage of thymic stromal lymphopoietin signaling improves acute lung injury in mice by regulating pulmonary dendritic cells.
Pan G; Liang Y; Lu L; Chen X; Wang M; Wang L; Yan C; Zhang W
Int J Clin Exp Pathol; 2015; 8(9):10698-706. PubMed ID: 26617780
[TBL] [Abstract][Full Text] [Related]
16. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
[TBL] [Abstract][Full Text] [Related]
17. The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.
Wu CC; Wu SY; Liao CY; Teng CM; Wu YC; Kuo SC
Br J Pharmacol; 2010 Oct; 161(3):643-58. PubMed ID: 20880402
[TBL] [Abstract][Full Text] [Related]
18. TSLP protects against sepsis-induced liver injury by inducing autophagy via activation of the PI3K/Akt/STAT3 pathway.
Wang H; Zhu J; Wei L; Wu S; Shang L; Ye X; Li S
Pathol Res Pract; 2022 Aug; 236():153979. PubMed ID: 35751928
[TBL] [Abstract][Full Text] [Related]
19. A platelet biomarker for assessing phosphoinositide 3-kinase inhibition during cancer chemotherapy.
Bowers RK; Marder P; Green LJ; Horn CL; Faber AL; Thomas JE
Mol Cancer Ther; 2007 Sep; 6(9):2600-7. PubMed ID: 17766838
[TBL] [Abstract][Full Text] [Related]
20. The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism.
Kauffenstein G; Bergmeier W; Eckly A; Ohlmann P; Léon C; Cazenave JP; Nieswandt B; Gachet C
FEBS Lett; 2001 Sep; 505(2):281-90. PubMed ID: 11566191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]